Report
Dave Nicoski ...
  • Ross LaDuke
EUR 226.08 For Business Accounts Only

Insights: Bullish Health care Services Stocks

Health Care Business Services offers attractive entry point -- add exposure

Group HC-30 Health Care Business Services is focused on harnessing technology to create solutions that improve patient outcomes and create efficiencies for medical professionals. This recommendation is at the intersection of Health Care, Technology, and Services, with the latter two Sectors being our favorite overweights at this point in time. Below we lay out what we believe is a compelling case to add exposure at current levels.

• Tabula Rasa HealthCare (TRHC): TRHC is our favorite opportunity out of today's three recommendations, as the stock exhibits fresh bullish price and RS inflections topside 11-month downtrends. We see no reason why TRHC can't repeat a move similar to the July 2017 through September 2018 timeframe -- add exposure to this small-cap growth stock... see chart below.

• Veeva Systems (VEEV) and R1 RCM (RCM): VEEV and RCM are two attractive names that are established leadership, and we expect this leadership to continue. Both remain in price and RS uptrends and have pulled back to logical support at their respective 50-day moving averages -- buy... see page 2.
Underlyings
Accretive Health

R1 RCM is a provider of revenue cycle management (RCM) services to healthcare providers, including health systems and hospitals, physicians groups, and municipal and private emergency medical service providers. The company's primary service offering consists of end-to-end RCM, which the company deploys through an operating partner relationship or a co-managed relationship. The company also provides modular services, allowing customers to engage the company for only specific components of its end-to-end RCM service offering, such as physician advisory services, practice management, and revenue capture services.

TABULA RASA HEALTHCARE

Tabula Rasa HealthCare is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is the company's main offering, and its cloud-based software applications, including EireneRx, MedWise and RxCompanion with its bundled prescription fulfillment and reminder packaging services, provide solutions for a range of payors, providers and other healthcare organizations. The company also provides health plan management services and pharmacy cost management services.

Veeva Systems

Veeva Systems provides industry cloud solutions for the life sciences industry. Veeva Commercial Cloud is a suite of multichannel customer relationship management applications, a commercial data warehouse, territory allocation and alignment applications, master data management applications and customer reference and data and services. Veeva Vault is the company's suite of cloud-based, enterprise content management applications that address the content management requirements for the company's customers'commercial functions, including medical and sales and marketing, and key research and development functions, including clinical, regulatory, quality, and, when available, safety.

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research
Dave Nicoski ...
  • Ross LaDuke
Other Reports from these Analysts
Dave Nicoski ...
  • Ross LaDuke

ResearchPool Subscriptions

Get the most out of your insights

Get in touch